1. U.S. Food and Drug Administration. Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. Draft guidance. 2006.
2. The OMERACT filter for outcome measures in rheumatology;Boers;J Rheumatol,1998
3. A new approach to defining disease status in ankylosing spondylitis: the Bath ankylosing spondylitis disease activity index;Garrett;J Rheumatol,1994
4. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy;J Rheumatol,1988
5. Feeling good rather than feeling better matters more to patients;Tubach;Arthritis Rheum,2006